A Biofourmis team member will be in contact soon. In the meantime, stay up-to-date with the latest Biofourmis news by following us on LinkedIn and Twitter.
What Our Customers Are Saying
“Through the partnership with Biofourmis, a leading company in research, development and commercialization of digital therapeutics, Chugai will set out to objectively assess pain associated with endometriosis and better understand its pathology.”
"The Everion® biosensor has become part of my daily habit. I wear it and forget about it and I know a care team is always there to make sure I am safe."
"The goal of this program is to leverage Biovitals® to remotely monitor patients and identify COVID-19 related physiological biomarkers that indicate deterioration in patients."
Previous
Next
Trusted by Leading Health Systems, Providers, Pharmaceutical Companies, and More
